When it comes to investing in dividend stocks, income investors are looking for stocks with strong dividends and solid businesses. At Extreme Investor Network, we believe in helping investors identify the best options to grow their portfolios. That’s why we’re excited to share insights on three unstoppable dividend stocks that could be worth considering: Abbott Laboratories (NYSE: ABT), Amgen (NASDAQ: AMGN), and AbbVie (NYSE: ABBV).
Abbott Laboratories is a Dividend King with a diverse business that has been paying dividends for over a century. Despite its modest dividend yield of 2%, Abbott has increased its dividends for 52 consecutive years. The company’s pharmaceutical, nutritional, medical device, and diagnostics units provide various growth opportunities, with positive organic growth reported in its most recent quarter. With a payout ratio of 67%, there is still room for the business to raise its dividend, making Abbott Laboratories a great long-term investment for buy-and-hold investors.
Amgen is a leading biotech company known for its innovation and diverse product portfolio generating over $1 billion in sales annually. Despite modest organic revenue growth in recent years, Amgen has exciting pipeline candidates like MariTide, which could potentially generate significant sales by 2030. With a dividend program that has increased payouts by 55% in the past five years and a forward yield of 2.74%, Amgen is a solid option for investors looking for a strong dividend stock.
AbbVie, a spinoff from Abbott, is another great dividend stock with a forward dividend yield of nearly 3.2%. Despite challenges following the loss of exclusivity for its top-selling drug, Humira, AbbVie has seen success with newer blockbuster drugs like Rinvoq and Skyrizi. With a growing pipeline of over 90 programs in development, including promising cancer, immunology, and neurological drugs, AbbVie remains well-positioned for future growth.
Overall, these three dividend stocks offer investors the opportunity to earn consistent income while benefiting from the growth potential of their respective businesses. For more expert insights and recommendations on investing in dividend stocks, be sure to follow Extreme Investor Network for the latest updates and analysis.